)
Sempra (SRE) investor relations material
Sempra Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record adjusted EPS of $4.69 for 2025, at the high end of guidance, driven by strong execution of value creation initiatives, robust utility investments, and successful asset sales unlocking significant equity value.
Announced a new $65 billion capital plan for 2026-2030, a 17% increase over the prior plan, with 95% targeted for utility investments, especially in Texas and California.
Completed major transactions, including the sale of a 45% stake in Sempra Infrastructure Partners for $10 billion and the agreement to sell Ecogas for $500 million, supporting capital recycling.
Invested $13 billion in 2025, prioritizing utility investments and improved returns, increasing rate base from $50 billion to $57 billion and declaring $1.7 billion in common dividends.
Focused on cost reduction, organizational efficiency, operational excellence, and wildfire risk mitigation.
Financial highlights
Full year 2025 adjusted earnings: $3.07 billion ($4.69/share), up from $2.97 billion ($4.65/share) in 2024; GAAP earnings: $1.80 billion ($2.75/share), down from $2.82 billion ($4.42/share) in 2024.
Q4 2025 adjusted earnings: $841 million ($1.28/share) vs. $960 million ($1.50/share) in Q4 2024.
Net income for 2025 was $2.07 billion, down from $3.5 billion in 2024.
Operating cash flow for 2025 was $4.57 billion, compared to $4.91 billion in 2024.
Capital expenditures for 2025 totaled $13 billion, up from $8.2 billion in 2024.
Outlook and guidance
Affirmed 2026 adjusted EPS guidance of $4.80-$5.30 and introduced 2027 guidance of $5.10-$5.70.
Issued 2030 EPS outlook of $6.70-$7.50, reflecting one of the highest projected growth rates in the sector.
Projected 11% five-year CAGR in overall rate base, with Sempra Texas expected to surpass California as the majority of rate base by 2030.
Targeting annual dividend growth of 2%-4% over the plan period, with dividend increased to $2.63/share annualized for 2026.
No need for common equity issuances to fund base capital plan due to improved operating cash flows and capital recycling.
- Q2 2024 earnings rose to $713M, with strong Texas/California growth and major projects advancing.SRE
Q2 20242 Feb 2026 - Q3 EPS fell, but guidance and $3B equity plan reaffirmed; Texas and LNG drive growth.SRE
Q3 202416 Jan 2026 - Q1 2025 EPS up, guidance affirmed, and major asset sales and capital investment drive outlook.SRE
Q1 20258 Jan 2026 - 2024 adjusted EPS hit $4.65, with a $56B capital plan and 7–9% EPS growth targeted.SRE
Q4 20247 Jan 2026 - Board refreshment, performance-based pay, and ambitious ESG targets headline the 2025 proxy.SRE
Proxy Filing1 Dec 2025 - Director nominee Jennifer M. Kirk will become CEO of Exubrion Therapeutics in May 2025.SRE
Proxy Filing1 Dec 2025 - Virtual meeting to elect 11 directors, ratify auditor, and approve executive pay.SRE
Proxy Filing1 Dec 2025 - Q2 2025 adjusted EPS held steady as utility growth, LNG progress, and guidance advanced.SRE
Q2 202523 Nov 2025 - Adjusted EPS up, major asset sale and Texas/LNG growth drive strong long-term outlook.SRE
Q3 20255 Nov 2025
Next Sempra earnings date
Next Sempra earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)